ACA-话题@MedSci

#ACA#

226篇内容 | 3710人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1652019, encodeId=ec90165201977, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=【精彩直播】2021版中国抗癌协会（CACA）乳腺癌外科治疗指南解读, objectType=article, longId=735477, objectId=2ab1e354775f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ab1e354775f, replyNumber=0, likeNumber=74, createdTime=2023-03-07, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ab1e354775f, moduleTitle=【精彩直播】2021版中国抗癌协会（CACA）乳腺癌外科治疗指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ab1e354775f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652026, encodeId=fefc16520260b, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Eur Acad Dermatol Venereol：不同显微外科手术治疗基底细胞癌后的复发率如何？, objectType=article, longId=739227, objectId=5266e3922743, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5266e3922743, replyNumber=0, likeNumber=95, createdTime=2023-08-19, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5266e3922743, moduleTitle=J Eur Acad Dermatol Venereol：不同显微外科手术治疗基底细胞癌后的复发率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5266e3922743)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652016, encodeId=7fb8165201682, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后, objectType=article, longId=728872, objectId=66cae28872f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66cae28872f3, replyNumber=0, likeNumber=90, createdTime=2022-11-22, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66cae28872f3, moduleTitle=J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66cae28872f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652025, encodeId=2f7416520256d, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：老年人基底细胞癌手术治疗负担、预后和总生存率的预测因素, objectType=article, longId=738683, objectId=5a99e386834e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a99e386834e, replyNumber=0, likeNumber=106, createdTime=2023-02-21, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a99e386834e, moduleTitle=J Am Acad Dermatol：老年人基底细胞癌手术治疗负担、预后和总生存率的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a99e386834e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652010, encodeId=3da116520106d, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Eur Acad Dermatol Venereol：外用非那雄胺可明显改善毛发数量，且耐受性良好, objectType=article, longId=725899, objectId=75b2e258991e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75b2e258991e, replyNumber=0, likeNumber=110, createdTime=2022-11-27, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75b2e258991e, moduleTitle=J Eur Acad Dermatol Venereol：外用非那雄胺可明显改善毛发数量，且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75b2e258991e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652018, encodeId=d98f165201826, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：阿布昔替尼可有效治疗中度至重度特应性皮炎，无论之前患者对度匹鲁单抗的反应如何, objectType=article, longId=733964, objectId=3601e3396485, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3601e3396485, replyNumber=0, likeNumber=118, createdTime=2023-06-27, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3601e3396485, moduleTitle=J Am Acad Dermatol：阿布昔替尼可有效治疗中度至重度特应性皮炎，无论之前患者对度匹鲁单抗的反应如何, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3601e3396485)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652021, encodeId=319e1652021ee, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=中国抗癌协会（CACA）【菁典研论】中青年学术纷享汇, objectType=article, longId=735749, objectId=82a0e357499a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82a0e357499a, replyNumber=0, likeNumber=74, createdTime=2022-11-30, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82a0e357499a, moduleTitle=中国抗癌协会（CACA）【菁典研论】中青年学术纷享汇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82a0e357499a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652004, encodeId=1601165200400, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=Mavacamten获中国“突破性治疗药物”认证，用于治疗梗阻性肥厚型心肌病, objectType=article, longId=298944, objectId=f5d829894405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5d829894405, replyNumber=0, likeNumber=0, createdTime=2022-09-13, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5d829894405, moduleTitle=Mavacamten获中国“突破性治疗药物”认证，用于治疗梗阻性肥厚型心肌病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5d829894405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652014, encodeId=18201652014a9, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：Omiganan可有效恢复轻中度特应性皮炎患者失调的菌群，但是不能改善患者的临床症状, objectType=article, longId=726573, objectId=2e80e2657345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e80e2657345, replyNumber=0, likeNumber=92, createdTime=2022-09-10, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e80e2657345, moduleTitle=J Am Acad Dermatol：Omiganan可有效恢复轻中度特应性皮炎患者失调的菌群，但是不能改善患者的临床症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e80e2657345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652027, encodeId=0ecb165202e63, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Eur Acad Dermatol Venereol：HPV型特异性分布在皮肤疣患者家庭成员和家庭床单中的分布, objectType=article, longId=739118, objectId=9519e391188f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9519e391188f, replyNumber=0, likeNumber=111, createdTime=2022-11-02, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9519e391188f, moduleTitle=J Eur Acad Dermatol Venereol：HPV型特异性分布在皮肤疣患者家庭成员和家庭床单中的分布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9519e391188f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652020, encodeId=7cb5165202099, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=联拓生物完成Mavacamten用于治疗中国梗阻性肥厚型心肌病患者的EXPLORER-CN III期关键临床试验的患者招募, objectType=article, longId=735587, objectId=f431e3558751, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f431e3558751, replyNumber=0, likeNumber=110, createdTime=2023-05-27, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f431e3558751, moduleTitle=联拓生物完成Mavacamten用于治疗中国梗阻性肥厚型心肌病患者的EXPLORER-CN III期关键临床试验的患者招募, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f431e3558751)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652000, encodeId=1f3b1652000ce, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：利他西尼和布雷波西尼间断用药治疗斑秃患者效果研究, objectType=article, longId=293678, objectId=5a4c2936e84f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a4c2936e84f, replyNumber=0, likeNumber=90, createdTime=2022-08-25, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a4c2936e84f, moduleTitle=J Am Acad Dermatol：利他西尼和布雷波西尼间断用药治疗斑秃患者效果研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a4c2936e84f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652007, encodeId=6ab3165200ea9, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒, objectType=article, longId=301104, objectId=bf1030110428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf1030110428, replyNumber=0, likeNumber=79, createdTime=2022-05-19, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf1030110428, moduleTitle=J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf1030110428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652015, encodeId=17f5165201507, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=ASCO：适应性体育活动显著改善晚期胰腺癌(APACaP)患者的生活质量, objectType=article, longId=728268, objectId=918ae28268b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=918ae28268b7, replyNumber=0, likeNumber=81, createdTime=2022-09-12, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=918ae28268b7, moduleTitle=ASCO：适应性体育活动显著改善晚期胰腺癌(APACaP)患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=918ae28268b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652024, encodeId=a8921652024aa, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：CTP-543治疗中重度斑秃的最佳剂量及疗效, objectType=article, longId=736728, objectId=7272e36728f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7272e36728f2, replyNumber=0, likeNumber=84, createdTime=2023-03-06, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7272e36728f2, moduleTitle=J Am Acad Dermatol：CTP-543治疗中重度斑秃的最佳剂量及疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7272e36728f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652008, encodeId=43f916520087a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=PARP 抑制剂 Rubraca (rucaparib)一线治疗晚期卵巢癌，显著延长了PFS, objectType=article, longId=302295, objectId=5d50302295d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d50302295d1, replyNumber=0, likeNumber=89, createdTime=2023-02-24, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d50302295d1, moduleTitle=PARP 抑制剂 Rubraca (rucaparib)一线治疗晚期卵巢癌，显著延长了PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d50302295d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652023, encodeId=f8ed165202309, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性 , objectType=article, longId=736658, objectId=f14be366588f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f14be366588f, replyNumber=0, likeNumber=107, createdTime=2022-10-03, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f14be366588f, moduleTitle=J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f14be366588f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652022, encodeId=f39616520226d, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Eur Acad Dermatol Venereol：健康人的表皮厚度是多少？, objectType=article, longId=735894, objectId=febce35894be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=febce35894be, replyNumber=0, likeNumber=93, createdTime=2023-02-14, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=febce35894be, moduleTitle=J Eur Acad Dermatol Venereol：健康人的表皮厚度是多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=febce35894be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651999, encodeId=8e4716519999a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：重度角化性掌跖湿疹的表皮内淋巴细胞和郎格汉斯细胞的病理研究, objectType=article, longId=293560, objectId=c8a9293560cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8a9293560cc, replyNumber=0, likeNumber=83, createdTime=2022-09-14, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8a9293560cc, moduleTitle=J Am Acad Dermatol：重度角化性掌跖湿疹的表皮内淋巴细胞和郎格汉斯细胞的病理研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8a9293560cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652013, encodeId=a718165201397, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：微针疗法可作为黄褐斑治疗的辅助手段，提高治疗效果, objectType=article, longId=726673, objectId=1d71e2667360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d71e2667360, replyNumber=0, likeNumber=98, createdTime=2022-10-29, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d71e2667360, moduleTitle=J Am Acad Dermatol：微针疗法可作为黄褐斑治疗的辅助手段，提高治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d71e2667360)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACA

2020-05-29

lishizhe (审核中...)

前往app查看评论内容

#ACA#

【精彩直播】2021版中国抗癌协会（CACA）乳腺癌外科治疗指南解读

2023-03-07

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：不同显微外科手术治疗基底细胞癌后的复发率如何？

2023-08-19

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后

2022-11-22

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：老年人基底细胞癌手术治疗负担、预后和总生存率的预测因素

2023-02-21

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：外用非那雄胺可明显改善毛发数量，且耐受性良好

2022-11-27

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：阿布昔替尼可有效治疗中度至重度特应性皮炎，无论之前患者对度匹鲁单抗的反应如何

2023-06-27

lishizhe (审核中...)

前往app查看评论内容

#ACA#

中国抗癌协会（CACA）【菁典研论】中青年学术纷享汇

2022-11-30

lishizhe (审核中...)

前往app查看评论内容

#ACA#

Mavacamten获中国“突破性治疗药物”认证，用于治疗梗阻性肥厚型心肌病

2022-09-13

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：Omiganan可有效恢复轻中度特应性皮炎患者失调的菌群，但是不能改善患者的临床症状

2022-09-10

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：HPV型特异性分布在皮肤疣患者家庭成员和家庭床单中的分布

2022-11-02

lishizhe (审核中...)

前往app查看评论内容

#ACA#

联拓生物完成Mavacamten用于治疗中国梗阻性肥厚型心肌病患者的EXPLORER-CN III期关键临床试验的患者招募

2023-05-27

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：利他西尼和布雷波西尼间断用药治疗斑秃患者效果研究

2022-08-25

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒

2022-05-19

lishizhe (审核中...)

前往app查看评论内容

#ACA#

ASCO：适应性体育活动显著改善晚期胰腺癌(APACaP)患者的生活质量

2022-09-12

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：CTP-543治疗中重度斑秃的最佳剂量及疗效

2023-03-06

lishizhe (审核中...)

前往app查看评论内容

#ACA#

PARP 抑制剂 Rubraca (rucaparib)一线治疗晚期卵巢癌，显著延长了PFS

2023-02-24

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性

2022-10-03

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：健康人的表皮厚度是多少？

2023-02-14

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：重度角化性掌跖湿疹的表皮内淋巴细胞和郎格汉斯细胞的病理研究

2022-09-14

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：微针疗法可作为黄褐斑治疗的辅助手段，提高治疗效果

2022-10-29

科室
- - 订阅+
  - 更多科室
工具
服务